title: [Chylous ascites revealing a systemic lupus erythematosus (L)].
authors.forename: Saloua
authors.initials: S
authors.lastname: B'Chir Hamzaoui
authors.forename: Meya
authors.initials: M
authors.lastname: Abdallah
authors.forename: Kamel
authors.initials: K
authors.lastname: Bouslama
authors.forename: Hafedh
authors.initials: H
authors.lastname: Mestiri
authors.forename: Lamia
authors.initials: L
authors.lastname: Kallel
authors.forename: Ali
authors.initials: A
authors.lastname: Harmel
authors.forename: Mourad
authors.initials: M
authors.lastname: Ennafaa
authors.forename: Skander
authors.initials: S
authors.lastname: M'Rad
authors.forename: Mohamed
authors.initials: M
authors.lastname: Ben Dridi
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000627:therapeutic use; D002915:Chylous Ascites / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D003937:Diagnosis, Differential; D004232:Diuretics / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000150:complications* / Q000175:diagnosis* / Q000188:drug therapy; D008875:Middle Aged; D012859:Sjogren's Syndrome / Q000209:etiology; D016896:Treatment Outcome
chemical_list: D000305:Adrenal Cortex Hormones; D018501:Antirheumatic Agents; D004232:Diuretics